Pharma

By Jonah Comstock September 14, 2016
The partnership announced in March between Johnson & Johnson subsidiary LifeScan and diabetes management company WellDoc has entered a new stage with a commercial partnership agreement, the companies announced yesterday.  "We’ve made considerable progress in our important relationship with LifeScan, Inc., which began earlier this year via a development agreement and a Johnson & Johnson...
By Jonah Comstock September 12, 2016
Today Walgreens shared new data from two studies that show the company's mobile tools -- both its mobile pill reminder and its Balance Rewards for Healthy Choices platform -- improve medication adherence for users.  “People increasingly want to become more engaged in their own health care, and with Walgreens digital health offerings, we give our customers the ability to positively impact their...
By Jonah Comstock August 30, 2016
Qualcomm Life and Boehringer Ingelheim have announced that they will work together to develop the next generation of Boehringer's Respimat connected inhaler. Propeller Health, which developed the original connected inhaler for Boehringer, will continue to work with Boehringer to at least market the existing version of the device.  "The overall goal for Boehringer Ingelheim is to create health...
By Heather Mack August 16, 2016
Pharmaceutical company AstraZeneca is beginning a clinical trial in collaboration with Quintiles looking at the impact of mobile medication reminders for people with chronic obstructive pulmonary disease (COPD). The proposed yearlong trial – which is still not yet recruiting participants – will be an intervention study involving an estimated 380 people with COPD divided into two groups. Both...
By Heather Mack August 16, 2016
Digital patient engagement company HealthPrize Technologies has partnered with Walgreens to offer its medication adherence platform on the drugstore chain’s website. The program will be offered to patients filling certain brand-name prescriptions for chronic conditions, starting with diabetes and eventually expanding to others. The platform will be web-based, but Walgreen's site is optimized for...
By Heather Mack August 8, 2016
Pharma company AstraZeneca, which offers a program called Fit2Me that provides diet and lifestyle support for patients with diabetes, is now expanding its offering to include patients with risks for cardiovascular disease. The program is also now available via an iOS and Android app, which has only been the case since the end of June. The customizable program focuses on four key areas of type 2...
By Heather Mack August 2, 2016
UK-based pharmaceutical giant GlaxoSmithKline has partnered with South San Francisco-based Verily to create Galvani Bioelectronics – a joint venture to develop implantable bioelectric medicines, a branch of medicine that works to fight diseases by targeting electrical signals in the body. Galvani, owned 55 percent by GSK and 45 percent by Verily (formerly known as Google Life Sciences) will have...
By Jonah Comstock July 28, 2016
Companion Medical, a stealthy San Diego-based company that received funding last year from Eli Lilly and Company, has received FDA 510(k) clearance for its Bluetooth-connected smart insulin pen and associated mobile app, called InPen. "FDA clearance of the InPen and mobile app represents a significant advancement in diabetes care," CEO Sean Saint, a veteran engineer of Dexcom, Medtronic, and...
By Jonah Comstock July 27, 2016
The market for digital dose inhalers for asthma and COPD will be worth $3.56 billion in 2024, according to a new prediction from Grand View Research.  Though connected inhalers are a new market, they've seen rapid growth in the last few years with interest from big pharma companies like AstraZeneca and Novartis, major device companies like Philips Respironics, as well as the newer, smaller...
By Jonah Comstock July 18, 2016
GlaxoSmithKline has launched the ResearchKit app that it told Buzzfeed it was working on more than a year ago, making it the first pharma company to get a ResearchKit study off the ground. The study is called PARADE, which the company says stands for Patient Rheumatoid Arthritis Data in the Real World. "We are the first in our industry to use Apple’s ResearchKit as part of our research, this time...